Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Niklas R Jørgensen"'
Autor:
Vivi FH Jensen, Maria Swanberg, Maria Herlin, Fiona E McGuigan, Niklas R Jørgensen, Kristina E Akesson
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-7 (2023)
Abstract Objective The class II transactivator (CIITA), encoded by the CIITA gene, controls expression of immune response regulators, which affect bone homeostasis. Previously, we investigated a functional CIITA polymorphism in elderly women. Women c
Externí odkaz:
https://doaj.org/article/554b9ce82a21486ab08c8b94787f46b6
Autor:
Pradeesh Sivapalan, Stina Willemoes Borresen, Josefin Eklöf, Marianne Klose, Freja S Holm, Ulla Feldt-Rasmussen, Maria Rossing, Niklas R Jørgensen, Rasmus L Marvig, Mohamad Isam Saeed, Torgny Wilcke, Niels Seersholm, Alexander G Mathioudakis, Jørgen Vestbo, Jens-Ulrik Stæhr Jensen
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0262898 (2022)
BackgroundSingle-nucleotide polymorphisms (SNPs) of the glucocorticoid receptor (GR) gene NR3C1 have been associated with an altered sensitivity to glucocorticoids, and thus may alter the therapeutic effects of glucocorticoids. We investigated the pr
Externí odkaz:
https://doaj.org/article/4c67dcc81fec43fd8b56f23d3f5a3b31
Autor:
Terese L. Katzenstein, Maria Wessman, Ellen Moseholm, Haakon Sandholdt, Ann-Brit E Hansen, Anne-Mette Lebech, Niklas R Jørgensen, Nina Weis
Publikováno v:
Cogent Medicine, Vol 8, Iss 1 (2021)
Abstract: Increased prevalence of low bone mineral density (BMD) and fractures among people living with HIV (PLWH) have been reported. The aim of the DANHIV-OSTEO study is to longitudinally monitor BMD among successfully treated PLWH. Here we report
Externí odkaz:
https://doaj.org/article/24ef396fe66447428811990aadd8942a
Autor:
Sophia Metz, Nikolaj T Krarup, Thomas Bryrup, Julie Støy, Ehm A Andersson, Christina Christoffersen, Matt J Neville, Malene R Christiansen, Anna E Jonsson, Daniel R Witte, Ulla Kampmann, Lars B Nielsen, Niklas R Jørgensen, Fredrik Karpe, Niels Grarup, Oluf Pedersen, Tuomas O Kilpeläinen, Torben Hansen
Publikováno v:
Metz, S, Krarup, N T, Bryrup, T, Støy, J, Andersson, E A, Christoffersen, C, Neville, M J, Christiansen, M R, Jonsson, A E, Witte, D R, Kampmann, U, Nielsen, L B, Jørgensen, N R, Karpe, F, Grarup, N, Pedersen, O, Kilpeläinen, T O & Hansen, T 2022, ' The Arg82Cys Polymorphism of the Protein Nepmucin Implies a Role in HDL Metabolism ', Journal of the Endocrine Society, vol. 6, no. 5, bvac034 . https://doi.org/10.1210/jendso/bvac034
Context Blood lipid levels are linked to the risk of cardiovascular disease and regulated by genetic factors. A low-frequency polymorphism Arg82Cys (rs72836561) in the membrane protein nepmucin, encoded by CD300LG, is associated with lower fasting co
Autor:
Eva W. Helge, Magnus Bendtsen, Simon Esrup, Niklas R. Jørgensen, Fajar A. Yulianto, Rizky S. Prawiradilaga
Publikováno v:
Medicine & Science in Sports & Exercise. 54:221-221
Autor:
Pradeesh Sivapalan, Stina Willemoes Borresen, Josefin Eklöf, Marianne Klose, Freja S. Holm, Ulla Feldt-Rasmussen, Maria Rossing, Niklas R. Jørgensen, Rasmus L. Marvig, Mohamad Isam Saeed, Torgny Wilcke, Niels Seersholm, Alexander G. Mathioudakis, Jørgen Vestbo, Jens-Ulrik Stæhr Jensen
Publikováno v:
PLoS ONE
Sivapalan, P, Borresen, S W, Eklöf, J, Klose, M, Holm, F S, Feldt-rasmussen, U, Rossing, M, Jørgensen, N R, Marvig, R L, Saeed, M I, Wilcke, T, Seersholm, N, Mathioudakis, A G, Vestbo, J, Jensen, J S & Ricciardolo, F L M (ed.) 2022, ' Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms ', PLoS ONE, vol. 17, no. 2, e0262898 . https://doi.org/10.1371/journal.pone.0262898
Sivapalan, P, Borresen, S W, Ekloef, J, Klose, M, Holm, F S, Feldt-Rasmussen, U, Rossing, M, Jorgensen, N R, Marvig, R L, Saeed, M I, Wilcke, T, Seersholm, N, Mathioudakis, A G, Vestbo, J & Jensen, J-U S 2022, ' Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids : Role of specific glucocorticoid receptor polymorphisms ', PLoS ONE, vol. 17, no. 2, 0262898 . https://doi.org/10.1371/journal.pone.0262898
PLoS ONE, Vol 17, Iss 2, p e0262898 (2022)
Sivapalan, P, Borresen, S W, Eklöf, J, Klose, M, Holm, F S, Feldt-rasmussen, U, Rossing, M, Jørgensen, N R, Marvig, R L, Saeed, M I, Wilcke, T, Seersholm, N, Mathioudakis, A G, Vestbo, J, Jensen, J S & Ricciardolo, F L M (ed.) 2022, ' Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms ', PLoS ONE, vol. 17, no. 2, e0262898 . https://doi.org/10.1371/journal.pone.0262898
Sivapalan, P, Borresen, S W, Ekloef, J, Klose, M, Holm, F S, Feldt-Rasmussen, U, Rossing, M, Jorgensen, N R, Marvig, R L, Saeed, M I, Wilcke, T, Seersholm, N, Mathioudakis, A G, Vestbo, J & Jensen, J-U S 2022, ' Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids : Role of specific glucocorticoid receptor polymorphisms ', PLoS ONE, vol. 17, no. 2, 0262898 . https://doi.org/10.1371/journal.pone.0262898
PLoS ONE, Vol 17, Iss 2, p e0262898 (2022)
Background Single-nucleotide polymorphisms (SNPs) of the glucocorticoid receptor (GR) gene NR3C1 have been associated with an altered sensitivity to glucocorticoids, and thus may alter the therapeutic effects of glucocorticoids. We investigated the p
Autor:
Ida E. Sønderby, Dennis van der Meer, Clara Moreau, Tobias Kaufmann, G. Bragi Walters, Maria Ellegaard, Abdel Abdellaoui, David Ames, Katrin Amunts, Micael Andersson, Nicola J Armstrong, Manon Bernard, Nicholas B Blackburn, John Blangero, Dorret Boomsma, Henry Brodaty, Rachel M. Brouwer, Robin Bülow, Rune Boen, Wiepke Cahn, Vince D Calhoun, Svenja Caspers, Christopher RK Ching, Sven Cichon, Simone Ciufolini, Benedicto Crespo-Facorro, Joanne E Curran, Anders M Dale, Shareefa Dalvie, Paola Dazzan, Eco de Geus, Greig Ian de Zubicaray, Sonja M. C. de Zwarte, Sylvane Desrivieres, Joanne L Doherty, Gary Donohoe, Bogdan Draganski, Stefan Ehrlich, Else Eising, Thomas Espeseth, Kim Fejgin, Simon Fisher, Tormod Fladby, Oleksandr Frei, Vincent Frouin, Masaki Fukunaga, Thomas Gareau, Tian Ge, David C. Glahn, Hans J. Grabe, Nynke A. Groenewold, Omar Gustafsson, Jan Haakvik, Asta Håberg, Jeremy Hall, Ryota Hashimoto, Jayne Y Hehir-Kwa, Derrek P. Hibar, Manon H.J. Hillegers, Per Hoffmann, Laurena Holleran, Avram J Holmes, Georg Homuth, Jouke-Jan Hottenga, Hilleke E. Hulshoff Pol, Masashi Ikeda, Neda Jahanshad, Christiane Jockwitz, Stefan Johansson, Erik G. Jönsson, Niklas R Jørgensen, Masataka Kikuchi, Emma EM Knowles, Kuldeep Kumar, Stephanie Le Hellard, Costin Leu, David Linden, Jingyu Liu, Arvid Lundervold, Astri J. Lundervold, Anne Manuela Maillard, Nicholas G Martin, Sandra Martin-Brevet, Karen A Mather, Samuel R. Mathias, Katie Louise McMahon, Allan F McRae, Sarah Medland, Andreas Meyer-Lindenberg, Torgeir Moberget, Claudia Modenato, Jennifer Monereo Sanchez, Derek Morris, Thomas W Mühleisen, Robin Murray, Jacob Nielsen, Jan E Nordvik, Lars Nyberg, Loes M Olde Loohuis, Roel A Ophoff, Michael J Owen, Tomáš Paus, Zdenka Pausova, Juan M Peralta, Bruce Pike, Carlos Prieto, Erin Burke Quinlan, Céline S Reinbold, Tiago Reis Marques, James J Rucker, Perminder S Sachdev, Sigrid S Sando, Peter R Schofield, Andrew J Schork, Gunter Schumann, Jean Shin, Elena Shumskaya, Ana I Silva, Sanjay M. Sisodiya, Vidar M Steen, Dan J. Stein, Lachlan Strike, Ikuo K Suzuki, Christian K. Tamnes, Alexander Teumer, Anbupalam Thalamuthu, Diana Tordesillas-Gutiérrez, Anne Uhlmann, Magnus O Ulfarsson, Dennis van 't Ent, Marianne BM van den Bree, Pierre Vanderhaeghen, Evangelos Vassos, Wei Wen, Katharina Wittfeld, Margaret J. Wright, Ingrid Agartz, Srdjan Djurovic, Lars T. Westlye, Hreinn Stefansson, Kári Stefánsson, Sebastien Jacquemont, Paul Thompson, Ole A. Andreassen, for the p. European Consortium
Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0f6d956875fef39e8a20576fad7ac02
https://doi.org/10.31234/osf.io/tbjxh
https://doi.org/10.31234/osf.io/tbjxh
Autor:
Sofus C. Larsen, Jake Turicchi, Gitte L. Christensen, Charlotte S. Larsen, Niklas R. Jørgensen, Marie-Louise K. Mikkelsen, Graham Horgan, Ruairi O’Driscoll, Joanna Michalowska, Cristiana Duarte, Sarah E. Scott, Inês Santos, Jorge Encantado, Antonio L. Palmeira, R. James Stubbs, Berit L. Heitmann
Publikováno v:
Larsen, S C, Turicchi, J, Christensen, G L, Larsen, C S, Jørgensen, N R, Mikkelsen, M L K, Horgan, G, O’Driscoll, R, Michalowska, J, Duarte, C, Scott, S E, Santos, I, Encantado, J, Palmeira, A L, Stubbs, R J & Heitmann, B L 2021, ' Hair Cortisol Concentration, Weight Loss Maintenance and Body Weight Variability : A Prospective Study Based on Data From the European NoHoW Trial ', Frontiers in Endocrinology, vol. 12, 655197 . https://doi.org/10.3389/fendo.2021.655197
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Copyright © 2021 Larsen, Turicchi, Christensen, Larsen, Jørgensen, Mikkelsen, Horgan, O’Driscoll, Michalowska, Duarte, Scott, Santos, Encantado, Palmeira, Stubbs and Heitmann. This is an open-access article distributed under the terms of the Crea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8d69bbc7fe35b93561ba052dadf8794
https://hdl.handle.net/10451/56510
https://hdl.handle.net/10451/56510
Autor:
Pradeesh Sivapalan, Stina W. Borresen, Josefin Eklöf, Marianne Klose, Freja S. Holm, Ulla Feldt-Rasmussen, Maria Rossing, Niklas R. Jørgensen, Rasmus L. Marvig, Mohamad Isam Saeed, Torgny Wilcke, Niels Seersholm, Alexander G. Mathioudakis, Jørgen Vestbo, Jens-Ulrik Stæhr Jensen
Background: Single-nucleotide polymorphisms (SNPs) of the glucocorticoid receptor (GR) gene NR3C1 have been associated with an altered sensitivity to glucocorticoids (GC), and thus may affect the therapeutic effects of GCs. We investigated the preval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adc56c36bbd537488dc1dbbffcc918e9
https://doi.org/10.21203/rs.3.rs-126008/v1
https://doi.org/10.21203/rs.3.rs-126008/v1
Autor:
Lærke S, Gasbjerg, Bolette, Hartmann, Mikkel B, Christensen, Amalie R, Lanng, Tina, Vilsbøll, Niklas R, Jørgensen, Jens J, Holst, Mette M, Rosenkilde, Filip K, Knop
Publikováno v:
Bone. 130
Infusion of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP) suppresses the bone resorption marker carboxy-terminal type 1 collagen crosslinks (CTX). Using separate and combined infusions of the selective GIP receptor (GIPR) an